Pulluri, Bhargavi <br/><br/>
Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance.  [electronic resource] 

 -  Pharmacological research  Sep 2017 
 - 95-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2017.07.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Immunotherapy<br/>Melanoma--drug therapy<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Tumor Microenvironment